We present the case of a 47-year-old male with a personal history of radically removed malignant melanoma (pT3bN2M0) who was receiving adjuvant nivolumab for the prevention of recurrence. He was admitted to our service complaining of epigastric pain and hyporexia after receiving the ninth dose of nivolumab. He underwent a preferential esophagogastroduodenoscopy, which showed intense inflammation limited to the stomach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17235/reed.2021.8295/2021 | DOI Listing |
Publication Analysis
Top Keywords
malignant melanoma
8
acute neutrophilic
4
neutrophilic gastritis
4
gastritis induced
4
induced nivolumab
4
nivolumab treatment
4
treatment non-
4
non- metastatic
4
metastatic malignant
4
melanoma case
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!